Table 4.

The relationship between lncRNA-ANRIL and SOX9 expression levels and the clinicopathology in patients with glioma

Factors	n	Relative expression of lncRNA-ANRIL	t	P	Relative expression of SOX9	t	P
Tumor grade			8.650	<0.001		6.621	<0.001
Grade I to II	79	2.47±0.35			0.39±0.04
Grade III to IV	63	2.02±0.27			0.44±0.05
Tumor diameter(cm)			3.602	<0.001		6.638	<0.001
≥4.51	77	2.29±0.31			0.45±0.04
<4.51	65	2.11±0.28			0.41±0.03
Distant metastasis			5.351	<0.001		5.027	<0.001
Yes	39	2.38±0.27			0.43±0.06
No	103	2.13±0.24			0.38±0.05
Family history of glioma			2.166	0.032		2.113	0.036
Yes	19	2.26±0.37			0.36±0.05
No	123	2.09±0.31			0.40±0.08